ClinicalTrials.gov
ClinicalTrials.gov Menu

CDK4/6 Inhibition in Locally Advanced/Metastatic Chordoma (NCT-PMO-1601)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03110744
Recruitment Status : Recruiting
First Posted : April 12, 2017
Last Update Posted : December 20, 2017
Sponsor:
Information provided by (Responsible Party):
Stefan Froehling, University Hospital Heidelberg

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : July 31, 2020
  Estimated Study Completion Date : July 31, 2021